In light of previous observations of cross-reactions between GFAP antibodies and epitopes of neurofilament-L in Alzheimer’s disease (AD) patients [24], this given study will particularly focus on the possibility that neuronal GFAP is a processing artefact, rather than a reactive process following brain injuries. Here, GFAP is linked to Alzheimer disease.